Head-to-head comparison between 18F-FDG PET/low-dose CT and 18F-FDG PET/contrast-enhanced CT in relapsing ovarian carcinoma: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Head-to-head comparison between 18F-FDG PET/low-dose CT and 18F-FDG PET/contrast-enhanced CT in relapsing ovarian carcinoma: a systematic review and meta-analysis

Published:2021-01-05 Issue:1 Volume:9 Page:73-81
ISSN:2281-5872
Container-title:Clinical and Translational Imaging
language:en
Short-container-title:Clin Transl Imaging

Author:

Massollo Michela,Treglia Giorgio,Trimboli Pierpaolo,Fiz Francesco,Ugolini Martina,Piccardo Arnoldo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s40336-020-00403-y.pdf

Reference34 articles.

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36

2. Moufarrij S, Dandapani M, Arthofer E et al (2019) Epigenetic therapy for ovarian cancer: promise and progress. Clin Epigenetics 11:7

3. Giornelli GH (2016) Management of relapsed ovarian cancer: a review. Springerplus 28(5):1197

4. Meyers MA (1973) Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119:198–206

5. Berek JS, Kehoe ST, Kumar L, Friedlander M (2018) Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 143(Suppl 2):59–78

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis;Annals of Nuclear Medicine;2023-07-09

2. Diagnostic Performance of Noninvasive Imaging Using Computed Tomography, Magnetic Resonance Imaging, and Positron Emission Tomography for the Detection of Ovarian Cancer: a Meta-analysis;2022-08-10

3. To Enhance or Not to Enhance? The Role of Contrast Medium 18F-FDG PET/CT in Recurrent Ovarian Carcinomas;Medicina;2021-06-01